The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.
Bolduc, Marilène; Baz, Mariana; Laliberté-Gagné, Marie-Ève; Carignan, Damien; Garneau, Caroline; Russel, Alexis; Boivin, Guy; Savard, Pierre; Leclerc, Denis.
; 14(8): 2563-2574, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30193813
Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine.
Yeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen.
IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.
A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection.
A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.
Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model.
Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles.
Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP.
Fabrication of nanoarchitectures templated by virus-based nanoparticles: strategies and applications.
DNA Mediated Vaccines Delivery Through Nanoparticles.